ArticleFrontiers in oncology2021

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma.

Yang Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.